Over 16 years ago a survey of the results of treatment for cancer in this region (Philip, 1949) made apparent the need for evaluation of our policy for breast cancer, which was treated mainly by radical surgery, with or without postoperative radiotherapy, and it was concluded that the treatment of operable breast cancer should not be resolved into fixed terms of surgery and radiotherapy. In planning treatment for a particular case the size and position of the growth, its extent so far as this could be assessed clinically, the age and general condition of the patient, and the existence of concomitant disease should each play a part. No significant improvement in our survival rate for the disease has been achieved by this policy except in so far as hormone therapy has been effective in dragging many terminal cases over the arbitrary five-year line. Nevertheless, it was thought that a report of the results of that treatment policy might be of some general interest.
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pectoral muscles not removed.
Treatment,
Alive at 5 Years five-year survival rates. The follow-up is incomplete for nine patients beyond the five-year line-from periods varying between 5.5 and 13 years-and one patient has been excluded from the survey because she could not be traced at the end of two years after treatment. Some patients treated over 20 years ago are still alive and on the follow-up register. The clinical staging used for the series is the one usually referred to as the " Manchester" method. The significant point is that one out of five patients in the clinical stage I group had the disease in the axillary nodes at the time of diagnosis, and this figure takes no account of possible internal mammary-node involvement or of distant metastases.
Clinical Staging
Operability Rates.-The operability rate of the 1930-9 series was contrasted with a 10-year period in the present series, and a rise of 15 % in the latter probably reflects an increasing awareness by the public of the possible significance of a lump in the breast, leading more patients to report earlier, and has some bearing also on increased five-year survival rates.
Clinical Staging Related to Delay.-The average length of history (Table II) No. alive at five years. During the period covered by the survey there were five modalities in the treatment of operable breast cancer. It is difficult, and perhaps pointless, to attempt to define clinical considerations which conditioned the selection of each particular method. It would be fair to say that " personal conviction " based on clinical experience, and training, were in large measure responsible for individual preferences in treatment. It is certainly true that operation alone, as practised in earlier years, was a more radical procedure than that obtaining today, but it is also true that the radical operation was in some instances carried out in earlier years for certain stage III cases for which it would not be considered now.
From 1944 onwards a modified radical mastectomy had some measure of support, entailing axillary dissection but leaving thi pectoral muscles behind.
With improved radiotherapeutic technique the morbidity associated with radiation became less, and therapy became more generally acceptable, so that preoperative irradiation was increasingly employed for patients in the stage III group who might subsequently be submitted to mastectomy.
The use of local mastectomy and x-ray therapy in the serie increased from 150% in 1940-4 to 320% in 1950-5, whereas the rate for radical mastectomy fell from 30% to 14% in the same periods.
Five-year survival rates for all cases treated by radical measures are as shown in Table VII , and, separately, those in the stage I and (Table VIII) .
Incidence of Scar Recurrence after Treatment In. this report the " scar " is defined as the area outlined by the breast flaps and the axillary bed, and the records of 951 patients subjected to " radical " measures are presented. Three main modalities in treatment were used-radical mastectomy, radical mastectomy and x-ray therapy, and local mastectomy followed by x-ray therapy. The recurrence rate for each method of treatment is shown in Table IX . In addition, the scarrecurrence rate for stage II cases is presented separately because it seems that conditions when treatment was applied by differing techniques show their closest approximation in this group. The figures show apparent advantage to radical mastectomy alone, but it should be observed that the cases so treated were in the main those most suited for the operation, usually fit patients with the disease either central or in the outer part of the breast, and to this extent they represent a selected group. On the same count it would be illogical to blame the higher
Metastases.- Table X 
Autonomy in Breast Cancer
It has been held generally that the disease can be cured only if it is confined to the breast at the time of treatment and perhaps also in a few cases where it has spread to the axillary nodes. To accept the theory of complete autonomy for untreated cancer or for cancer beyond the confines of the breast at the time of treatment calls for all emphasis on early diagnosis as the critical factor in prognosis. To this end much thought is being directed to intelligently planned educative measures, supported by adequate. bed accommodation, to preclude delay in treatment. Park and Lees (1951) concluded that it had not been proved that the survival rate for cancer of the breast, with the use of the five-year survival rate as an index, was affected by treatment at all, and held that the evidence strongly suggested that treatment was quite ineffectual in reducing the incidence of death from metastatic spread. They are convinced that if treatment is in any way effective the effectiveness cannot be greater than that required to increase the overall five-year rate by more than 5 to 10%. On the other hand, Bloom et al. (1962) Kreyberg and Christiansen (1953) reported that even the smallest carcinomas, those of the size of a pea or a bean, had a fatal outcome in four out of ten cases when followed up over 10 to 20 years, and they also showed that nearly two-thirds of the patients had metastases when arriving for treatment. Bloom (1950) Setting aside for the moment the postulate that the host may not be entirely defenceless against wider dissemination, it is accepted that radical mastectomy alone has produced high fiveyear survival rates in the hands of many surgeons. This figure is highest for those patients in whom no secondary disease has been detected histologically in the axillary nodes. Furthermore, the five-year survival rate for those patients whose axillary nodes are involved, though less than for stage I, is not inconsiderable. This tailing off in the case of the stage II group does not necessarily condemn the radical procedure as ineffectual in clearing the disease from the axilla, because this feature may be conditioned by dissemination beyond the operative field before treatment. Nevertheless, radical mastectomy can rarely, if indeed ever, confer any practical advantage for those lesions occupying the inner part of the breast, because of their high incidence of internal mammary-node involvement. Its employment for any stage III case can seldom be justified, and of course it has no meaning for the stage IV group.
In some patients, probably not a large number, the disease is of a radioresistant character, and for these radical mastectomy must offer the greatest chance of cure, but unfortunately this type of lesion cannot be recognized clinically.
The main objections to the radical operation usually quoted are shoulder-joint disability and arm oedema, both of which are minimal with careful operative technique and postoperative supervision. It might be mentioned also that less radical surgical techniques combined with radiotherapy are by no means devoid of morbidity.
Irradiation Alone
Radium therapy was used alone or in association with surgery for some patients in this centre up to 1936, and, though it produced some five-year survivors, it was soon given up because of its morbidity-radionecrosis of skin and ribs, brachial neuritis, and sometimes haemorrhage.
X-ray therapy can apparently inactivate some breast cancers. More often than not its success when used alone lies in surrounding viable tumour tissue with a dense bed of fibrous tissue ; it probably prolongs the patient's life, but not because it cures the disease. In association with radical surgery it has been indicated in several publications as increasing the five-year survival rate to a significant degree. Here, again, this effect may not always be due to sterilization of tumour residue in the breast or axilla, but because it extends the treatment field to include the supraclavicular nodes, and, less effectively, the parasternal lymphatics on the affected side, and it is not irrational to postulate that some of its effect may be on free circulating tumour cells in the blood stream. X-ray therapy alone, Taken overall, the effectiveness of local mastectomy and x-ray therapy has been proved; it has a low morbidity, and when it is generally applied the published absolute five-year survival rate is of the order of 42%.
Radical Mastectomy and Postoperative Radiotherapy
Paterson and Marion Russell (1959) reported the result of a clinical trial based on random selection and designed to attempt an objective assessment of the actual value of radiotherapy when given after radical mastectomy: a total number of 1,461 cases were covered by this study, and the trial was divided into two series which cannot be summated, as distinctly different methods of postoperative radiotherapy were employed in the treated cases.
In the first period the main irradiated area was the operation flap and the axilla (quadrate series 720 cases). In the second period the radiation was primarily directed towards the axilla, the supraclavicular area, and the parasternal region (peripheral series of 741 cases). Ovarian ablation is accepted as of value in certain age groups. The potential role of chemotherapy in operable breast cancer is discussed.
I have to thank my colleagues in the Royal Infirmary, Aberdeen, for permission to use their case records in the preparation of this paper, and especially Dr. Roy Weir for his guidance and comment on the statistics.
There are several problems associated with the homotransplantation of tissue in man, not least of which is the homograft rejection mechanism. Certainly with kidney transplantation the technical problems of implantation appear subservient to those concerned with the rejection phenomenon.
The role of lymphocytes in this immune response is not fully understood, but there is ample evidence of their special importance (Woodruff, 1960) . Loss of lymphocytes from the thoracic duct in rats resulted in severe depression or abolition of the primary immune response (McGregor and Gowans, -1963) , and multiple methods of producing lymphocyte reduction have been used as a means of prolonging homograft survival in both experimental animals and man.
Over the past four years we have been particularly interested in the treatment of melanoma with endolymphatic 1311 Lipiodol. Before this period lymph-node metastases from melanoma had been treated with endolymphatic 198Au (Jantet et al., 1964) .
Complete records have been made in a series of 50 patients who received endolymphatic 131I therapy for melanoma. These investigations included preoperative and postoperative leucocyte estimations. It was noted in our early investigations that the endolymphatic therapy in the range of dosages used did not depress the total leucocyte count markedly, though this did occur in the occasional patient. However, of more significance was the feature that in several patients a relative and absolute lymphopenia occurred. This paper is concerned with a detailed analysis of these patients, with particular reference to the achievement of a relatiVe and absolute lymphocyte depression after endolymphatic therapy.
Treatment Policy for Melanoma
Our therapeutic approach to the patient with malignant melanoma is to follow the initial wide excision of the primary lesion with endolymphatic therapy via the lymphatics draining the site of excision. The endolymphatic treatment is usually given three weeks after the time of excision, though when the diagnosis is assured synchronous treatment is occasionally given.
Should the lymph nodes be clinically and radiologically negative then this plan of action is usually regarded as sufficient, and the patient is subsequently followed carefully in the outpatient department. In some patients node dissections have been made at varying intervals after endolymphatic treatment. Microscopical examination often reveals total destruction of lymph nodes in this group (see Fig. 1 
